0

chemotherapy for breast cancer patients

Tài liệu Screening for Breast Cancer: Systematic Evidence Review Update for the U. S. Preventive Services Task Force doc

Tài liệu Screening for Breast Cancer: Systematic Evidence Review Update for the U. S. Preventive Services Task Force doc

Sức khỏe giới tính

... individual risks for breast cancer 60-85% and may be identified in 5-10% of all breast cancer cases.28 Personal history of noninvasive breast cancer or previous abnormal breast biopsy containing ... participants for women age 40-49 years that reported relative risk (RR) reduction in breast cancer mortality. We conducted similar updates for other age groups for context. We used breast cancer ... risk for breast cancer mortality of 0.83 (95% confidence interval [CI], 0.66-1.04) for women randomly assigned to screening, and a number needed to invite for screening to prevent one breast cancer...
  • 95
  • 1,014
  • 0
Tài liệu SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY ppt

Tài liệu SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY ppt

Sức khỏe giới tính

... background for our information in this leaflet below. SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY What are the benefits and harms of attending a screening programme for breast cancer? ... treatment for breast cancer in Norway: comparative analysis of cancer registry data. BMJ 2011;343:d4692. 20. NHS cancer screening programmes. BASO Breast Audit 1999/2000. www.cancerscreening.nhs.uk/breastscreen/publications.html ... disease and cancer. It therefore no longer seems reasonable to attend for breast cancer screening. In fact, by avoiding going to screening, a woman will lower her risk of getting a breast cancer...
  • 15
  • 528
  • 3
báo cáo hóa học:

báo cáo hóa học:" PAR1 is selectively over expressed in high grade breast cancer patients: a cohort study" docx

Hóa học - Dầu khí

... subtypes inclinical breast cancer. Int J Cancer 2000, 89:209-212.19. Elston W, Ellis IO: Pathological prognostic factors in breast cancer. The value of histologic grade in breast cancer: expe-rience ... purposes)PAR1 expression in breast cancer patientsFigure 1PAR1 expression in breast cancer patients. Western blots showing PAR and EGFR expression profiles of tumor biopsy samples from patients with infiltrating ... prognostic factor for invasive breast cancer. Indeed, we found that the clin-ical status or stage of breast cancer in our patients was cor-related with PAR1 overexpression: patients overexpressingPAR1...
  • 10
  • 489
  • 0
báo cáo hóa học:

báo cáo hóa học: " Responsiveness of the EQ-5D in breast cancer patients in their first year after treatment" ppt

Hóa học - Dầu khí

... examined in breast cancer patients after treat-ment. Therefore, we use data from a randomized clinicaltrial investigating several follow-up strategies for cura-tively treated breast cancer patients ... good prognosis, breast cancer is themost prevalent cancer in the world today [1]. After cura-tive treatment for breast cancer, women attend frequentfollow-up visits to be examined for possible ... group program aftercurative treatment for breast cancer (MaCare trial, ISRCTN74071417) [10]. Patients in the trial were all female,treated for breast cancer with curative intent, and had noconcomitant...
  • 7
  • 379
  • 0
Báo cáo sinh học:

Báo cáo sinh học: " Encapsulation of docetaxel in oily core polyester nanocapsule intended for breast cancer therapy" pptx

Điện - Điện tử

... nanocapsule form. This observation was consistent with a previous report [48] related to a nanoparticulate form of another anticancer drug (doxorubicin) tested on a different breast cancer cell ... characterized for particle size, zeta potential, EE%, drug release kinetics, morphology, crystallinity, and cytotoxicity on the SUM 225 breast cancer cell line by dynamic light scattering, high performance ... acceptance. Fully formattedPDF and full text (HTML) versions will be made available soon.Encapsulation of docetaxel in oily core polyester nanocapsule intended for breast cancer therapyNanoscale...
  • 24
  • 474
  • 0
báo cáo hóa học:

báo cáo hóa học:" Heath-related quality of life in Spanish breast cancer patients: a systematic review" pptx

Hóa học - Dầu khí

... the for- mer, the most used in Europe for breast cancer are theEuropean Organization for Research and Treatment of Cancer Core Cancer Quality Life Questionnaire(EORTC QLQ-C30) and its breast- cancer- speci ... health-related quality of life for women with breast cancer. Breast Cancer Res Treat 2005, 93:217-226.57. Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA: Breast cancer in older women: ... EuropeanOrganization for Research and Treatment of Cancer; EORTC QLQ-BR23:European Organization for Research and Treatment of Cancer Quality LifeQuestionnaire Breast Cancer Specific Module;...
  • 10
  • 479
  • 0
Báo cáo hóa học:

Báo cáo hóa học: " A Novel Docetaxel-Loaded Poly (e-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment" pot

Hóa học - Dầu khí

... inhuman breast cancer cells and therefore have considerablepotential for treatment of breast cancer. Keywords Nanoparticles Á MDR Á Pluronic F68 ÁPoly (e-caprolactone) Á Docetaxel Á Breast cancer Introduction Cancer ... multidrug resistance inhuman breast cancer cells and therefore have considerablepotential for treatment of breast cancer. Acknowledgments The authors are grateful for financial supportfrom the ... 54.37% for TaxotereÒto 49.16% (i.e. a11.42% increase in cytotoxicity, p [ 0.05) for PCL NPformulation and 36.63% (i.e. a 38.88% increase in cyto-toxicity, p \0.05) for PCL/Pluronic F68 NP formulation.Similarly,...
  • 10
  • 363
  • 0
Báo cáo sinh học:

Báo cáo sinh học: "Reasons for breast cancer heterogeneity" pptx

Báo cáo khoa học

... treatment is therefore not as effective as itshould be. Mortality due to breast cancer is decreasing inmost western countries, because of mass screening, frequentuse of post-operative chemotherapy ... understood breast cancer heterogeneitybetter. Two recent papers in Genome Biology from thelaboratories of Carlos Caldas [1] and Eric Miska [2] usemolecular methods to classify breast cancers ... hheetteerrooggeenneeiittyyBecause breast cancer heterogeneity arises from manydifferent factors, several directions of research must bepursued simultaneously if we are to understand and copewith the different forms of breast...
  • 4
  • 422
  • 0
Báo cáo toán học:

Báo cáo toán học: "BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases" potx

Báo cáo khoa học

... does it relate to breast cancer in African-American women? Cancer, 2005, 103(8): 1540-1550. 15. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative ... BRCA1 mutations to breast cancer in a North African population, we analysed genomic DNA from breast cancer cases ascertained in Algiers. Both familial cases (at least three breast cancers in the ... differences in breast cancer patterns. Age-standardized incidence per 100,000 for breast cancer in 2002 was 23.5 in Algeria versus 91.9 in France [4]. The size and grade of breast tumors...
  • 6
  • 207
  • 0
báo cáo khoa học:

báo cáo khoa học: "Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients" pot

Báo cáo khoa học

... IL-6 and CRP in breast carcinoma, and to correlate them with the staging of the disease and the prognosis.Methods: 59 female patients admitted for breast cancer were identified for the study and ... J Cancer 1991, 64:1133-1138.12. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer: a study of 1409 cases of which 539 have been followed up for 15 years. Br J Cancer ... JL: Confirmation of a prognostic index in primary breast cancer. Br J Cancer 1987, 56:489-492.14. Lonn U, Lonn S, Nilsson B, Stenkvist B: Breast cancer: prognosticsignificanceof c-erb-B2 and...
  • 6
  • 279
  • 0
báo cáo khoa học:

báo cáo khoa học: "Axillary lymph node dissection for breast cancer utilizing Harmonic Focus®" pps

Báo cáo khoa học

... CS, Nelson BK: Seroma formationfollowing breast cancer surgery. Breast J 2003, 5:385-8.10. Woodworth PA, McBoyle MF, Helmer SD, Beamer RL: Seroma formationafter breast cancer surgery: incidence ... ofseromas following breast cancer surgeries: seromas following breast cancer surgeries. Breast J 2007, 13:588-92.21. Burak WE Jr, Goodman PS, Young DC, Farrar WB: Seroma formationfollowing ... dissection for breast cancer utilizing Harmonic FocusđKatherine T Ostapoff1*, David Euhus1, Xian-Jin Xie2, Madhu Rao1, Amy Moldrem1and Roshni Rao1AbstractBackground: For patients...
  • 5
  • 349
  • 0

Xem thêm